-+ 0.00%
-+ 0.00%
-+ 0.00%

De Dietrich joins PIPAC consortium to develop continuous API manufacturing platform

PUBT·08/07/2026 06:51:33
Listen to the news
De Dietrich joins PIPAC consortium to develop continuous API manufacturing platform
  • De Dietrich joined the PIPAC consortium with Alysophil, Bruker, Novalix to validate a continuous API manufacturing platform.
  • Pilot program completed, combining continuous-flow chemistry with AI-driven real-time analytics, monitoring, control to replace batch production.
  • Platform validated through continuous-flow production of fentanyl, a highly regulated API, supporting potential expansion to other pharmaceutical ingredients.
  • Project targets supply-chain resilience, supporting efforts to reshore API production amid recent disruptions, geopolitical uncertainty, capacity concentration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. De Dietrich SAS published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.